EPITHELIOD SARCOMA (ES)

Clinical trials for EPITHELIOD SARCOMA (ES) explained in plain language.

Never miss a new study

Get alerted when new EPITHELIOD SARCOMA (ES) trials appear

Sign up with your email to follow new studies for EPITHELIOD SARCOMA (ES), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Cancer patients get chance to continue promising drug in Long-Term safety study

Disease control Completed

This study allowed patients with various cancers who had benefited from the drug tazemetostat in earlier trials to continue receiving it. The main goal was to monitor the drug's long-term safety in these patients. It was open to people who had not seen their cancer worsen and cou…

Matched conditions: EPITHELIOD SARCOMA (ES)

Phase: PHASE1, PHASE2 • Sponsor: Epizyme, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

EPITHELIOD SARCOMA (ES)

Get alerted when new EPITHELIOD SARCOMA (ES) trials appear

Cancer patients get chance to continue promising drug in Long-Term safety study